NCT00136968View on ClinicalTrials.gov

Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

May 31, 2005

Conditions
Fungal Infection
Interventions
DRUG

Voriconazole

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
collaborator

Mclean Hospital

OTHER

lead

Pfizer

INDUSTRY

NCT00136968 - Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy | Biotech Hunter | Biotech Hunter